His main research concerns Biochemistry, Protein structure, Internal medicine, Biophysics and Spider silk. His is involved in several facets of Biochemistry study, as is seen by his studies on Peptide, Pulmonary surfactant, Peptide sequence, Amino acid and Membrane protein. His Protein structure study combines topics from a wide range of disciplines, such as Fibril, Amyloid disease, Neurodegeneration, Circular dichroism and Amyloid.
Jan Johansson has researched Internal medicine in several fields, including Gastroenterology, Endocrinology and Cardiology. In his research, Cytotoxicity and Catalytic cycle is intimately related to Protein aggregation, which falls under the overarching field of Biophysics. Within one scientific family, Jan Johansson focuses on topics pertaining to Spinning under Spider silk, and may sometimes address concerns connected to Aqueous solubility.
Jan Johansson mostly deals with Biochemistry, Internal medicine, Pulmonary surfactant, Spider silk and Peptide. His Biochemistry research includes themes of Amyloid disease and Amyloid. His Internal medicine research incorporates elements of Gastroenterology, Endocrinology and Cardiology.
Jan Johansson interconnects Chromatography, Phospholipid and Respiratory distress in the investigation of issues within Pulmonary surfactant. The concepts of his Spider silk study are interwoven with issues in Biophysics, Nanotechnology and Cell biology. His study looks at the relationship between Peptide and topics such as Stereochemistry, which overlap with Helix.
The scientist’s investigation covers issues in Internal medicine, Spider silk, Cell biology, In vitro and Biophysics. The Internal medicine study combines topics in areas such as Gastroenterology and Cardiology. His primary area of study in Spider silk is in the field of Spidroin.
The various areas that he examines in his Cell biology study include Neurodegeneration and Amyloid. His research investigates the connection with Biophysics and areas like Protein aggregation which intersect with concerns in Peptide, Thioflavin, Monomer and Cytosol. His Integral membrane protein 2B research is under the purview of Biochemistry.
Jan Johansson spends much of his time researching Internal medicine, Cell biology, Spider silk, Neurodegeneration and Pharmacology. His Cell biology research is multidisciplinary, incorporating perspectives in Fibril and In vitro. His In vitro study integrates concerns from other disciplines, such as Mutant, Chaperone, Integral membrane protein 2B, Peptide and Amyloid.
Jan Johansson combines subjects such as Alzheimer's disease, Biochemistry and Transmembrane protein with his study of Amyloid. His Spider silk research is multidisciplinary, relying on both Peptide sequence and Spinning. He works mostly in the field of SILK, limiting it down to concerns involving Biophysics and, occasionally, Protein domain.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Arrest of -Amyloid Fibril Formation by a Pentapeptide Ligand
Lars O. Tjernberg;Jan Näslund;Fredrik Lindqvist;Jan Johansson.
Journal of Biological Chemistry (1996)
Conformation-dependent Antibacterial Activity of the Naturally Occurring Human Peptide LL-37
Jan Johansson;Gudmundur H. Gudmundsson;Martı́n E. Rottenberg;Kurt D. Berndt.
Journal of Biological Chemistry (1998)
Molecular basis for amyloid fibril formation and stability
O. Sumner Makin;Edward Atkins;Pawel Sikorski;Jan Johansson.
Proceedings of the National Academy of Sciences of the United States of America (2005)
Prevalence and risk factors for ischemia, leak, and stricture of esophageal anastomosis: gastric pull-up versus colon interposition.
John W Briel;Anand P Tamhankar;Jeffrey A Hagen;Steven R DeMeester.
Journal of The American College of Surgeons (2004)
Self-assembly of spider silk proteins is controlled by a pH-sensitive relay
Glareh Askarieh;My Hedhammar;Kerstin Nordling;Alejandra Saenz.
Role of C-peptide in human physiology
John Wahren;Karin Ekberg;Jan Johansson;Mikael Henriksson.
American Journal of Physiology-endocrinology and Metabolism (2000)
High density lipoproteins and coronary atherosclerosis. A strong inverse relation with the largest particles is confined to normotriglyceridemic patients.
J Johansson;L A Carlson;C Landou;A Hamsten.
Arteriosclerosis, Thrombosis, and Vascular Biology (1991)
Effects of Recombinant Apolipoprotein A-IMilano on Aortic Atherosclerosis in Apolipoprotein E–Deficient Mice
Prediman K. Shah;Jan Nilsson;Sanjay Kaul;Michael C. Fishbein.
Molecular structures and interactions of pulmonary surfactant components.
Jan Johansson;Tore Curstedt.
FEBS Journal (1997)
Prediction of amyloid fibril-forming proteins.
Yvonne Kallberg;Magnus Gustafsson;Bengt Persson;Johan Thyberg.
Journal of Biological Chemistry (2001)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: